Anne-Catherine Servais

Anne-Catherine Servais

Auto-generated profile, based on publicly available information

Anne-Catherine Servais

Laboratory for the Analysis of Medicines (LAM), Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
CPChloé Parulski
Chloé Parulski
LBLaure-Anne Bya
Laure-Anne Bya
JGJustine Goebel
Justine Goebel
ASAnne-Catherine Servais
Anne-Catherine Servais
ALAnna Lechanteur
Anna Lechanteur
BEBrigitte Evrard
Brigitte Evrard

27 February 2019 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
LNLaurent Nyssen
Laurent Nyssen
MFMarianne Fillet
Marianne Fillet
ECEtienne Cavalier
Etienne Cavalier
ASAnne‐Catherine Servais
Anne‐Catherine Servais

21 November 2019 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
RYRazieh Yazdani
Razieh Yazdani
Masoud Shams-BakhshMasoud Shams-Bakhsh
Masoud Shams-Bakhsh
AHAfshin Hassani-Mehraban
Afshin Hassani-Mehraban
SASeyed Shahriar Arab
Seyed Shahriar Arab
NTNicolas Thelen
Nicolas Thelen
ASAnne-Catherine Servais
Anne-Catherine Servais
Background: Virus-like particle (VLP) platform represents a promising approach for the generation of efficient and immunogenic subunit vaccines. Here, the feasibility of using grapevine fanleaf virus (GFLV) VLPs as a new carrier for the presentation of human papillomavirus (HPV) L2 epitope was studied. To achieve this goal, a model of the HPV L2 epitope secondary structure was predicted and its insertion within 5 external loops in the GFLV capsid protein (CP) was evaluated. Results: The epitope sequence was genetically inserted in the αB-αB” domain C of the GFLV CP, which was then over-expressed in Pichia pastoris and Escherichia coli. The highest expression yield was obtained in E. coli. Using this system, VLP formation requires a denaturation-refolding step, whereas VLPs with lower production yield were directly formed using P. pastoris, as confirmed by electron microscopy and immunostaining electron microscopy. Since the GFLV L2 VLPs were found to interact with the HPV L2 antibody under native conditions in capillary electrophoresis and in ELISA, it can be assumed that the inserted epitope is located at the VLP surface with its proper ternary structure. Conclusions: The results demonstrate that GFLV VLPs constitute a potential scaffold for surface display of the epitope of interest.

1 June 2020 in TrAC Trends in Analytical Chemistry
Verified
Journal Article
Closed access
MHMaryam Hemmati
Maryam Hemmati
CNCindy Nix
Cindy Nix
JCJacques Crommen
Jacques Crommen
ASAnne-Catherine Servais
Anne-Catherine Servais
MFMarianne Fillet
Marianne Fillet

22 June 2022 in Journal of Chromatography A
Verified
Journal Article
Closed access
MKMaryam Ghassemi K
Maryam Ghassemi K
ADAlice Demelenne
Alice Demelenne
JCJacques Crommen
Jacques Crommen
ASAnne-Catherine Servais
Anne-Catherine Servais
MFMarianne Fillet
Marianne Fillet

22 January 2021 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
PEPaul Emonts
Paul Emonts
ASAnne‐Catherine Servais
Anne‐Catherine Servais
EZEric Ziemons
Eric Ziemons
PHPhilippe Hubert
Philippe Hubert
MFMarianne Fillet
Marianne Fillet
ADAmandine Dispas
Amandine Dispas